한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

in recent years, with the promotion of national medical insurance negotiations, drug prices have shown a downward trend, and many people have begun to feel the balance between "good quality" and "low price". however, these changes have also brought new challenges.

1. allocation of medical resources and patient needs: the prices of imported original drugs are often higher than those of generic drugs, but the market demand is still huge. patients face difficulties in choosing and cannot afford the high prices of imported drugs, while hospitals need to balance patient demand and drug supply, which brings new challenges.

2. selected procurement model and drug supply chain: the centralized procurement model with volume restrictions is an important way to solve the problem of medical resource allocation. however, problems such as "price reduction death" and "bid death" of winning products, and the squeezing of the living space of non-winning drugs still exist and need to be further improved.

3. government regulation and market rules: reasonable control of drug prices is an important means to protect people's health and economic development. however, regulatory authorities are also faced with the problem of how to balance market rules and national interests. for example, full research on drug costs and profits, reasonable evaluation of drug prices, respect for market rules, setting price bottom lines, leaving profit space for manufacturers, and ensuring the healthy operation of enterprises will find the direction for promoting the balance between "good quality" and "low price".

4. patients’ right to choose and medical insurance payment ratio: medical insurance negotiations are an important means to reduce drug prices, but patients' right to choose between the medical insurance payment ratio and the out-of-pocket payment ratio also needs to be more clearly reflected.

5. new opportunities brought by new technologies and innovative drugs: with the advancement of science and technology and the research and development of new drugs, china's pharmaceutical industry will usher in new development opportunities. for example, new technologies and innovative drugs can break the boundaries between "good quality" and "low price" and provide patients with more convenient and efficient medical services.

in short, drug prices are a complex issue that requires joint efforts from the government, hospitals, pharmaceutical companies and other parties to find a balance and provide patients with better and more affordable medical services.